Induction of Connective Tissue Growth Factor by Angiotensin II
Authors:
- 1 October 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (10) , 1782-1787
Abstract
Objective— Angiotensin II is recognized as one of the major mediators of cardiovascular pathology. Because connective tissue growth factor (CTGF) is involved in the pathophysiologic processes underlying fibrotic diseases, its regulation by angiotensin II was investigated. Methods and Results— In the 2-kidney, 1-clip model of renovascular hypertension, increased expression of CTGF was detectable in the hypertrophic left ventricle. By activation of angiotensin II type 1 receptors, angiotensin II caused rapid expression of CTGF mRNA and protein in a human fibroblast cell line. Activation of the p42/44 mitogen-activated protein (MAP) kinase signaling pathway proved to be essential for angiotensin II–stimulated CTGF expression. Inhibition of MAP kinase activation by forskolin prevented CTGF induction. Inhibition of the isoprenylation of small GTPases by simvastatin or pretreatment of the cells with toxin B reduced basal CTGF expression below detection limits and prevented induction by angiotensin II. Specific interference with RhoA signaling by Y27632 primarily reduced basal CTGF expression. There was no significant reduction of expression of angiotensin II type 1 receptors by simvastatin. These data indicate cooperation between the Rho signaling and the angiotensin II–activated MAP kinase pathways. Conclusions— Direct induction of CTGF by angiotensin II is indicative of a role for CTGF in angiotensin II–mediated fibrosis and might be a target of antifibrotic interventions.Keywords
This publication has 22 references indexed in Scilit:
- Prostacyclin derivatives prevent the fibrotic response to TGFβ2 by inhibiting the Ras/MEK/ERK pathwayThe FASEB Journal, 2002
- TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cellsAmerican Journal of Physiology-Renal Physiology, 2002
- Global chimeric exchanges within the intracellular face of the bradykinin B2 receptor with corresponding angiotensin II type Ia receptor regions: Generation of fully functional hybrids showing characteristic signaling of the AT1a receptorJournal of Cellular Biochemistry, 2002
- Rho‐dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins)British Journal of Pharmacology, 2001
- Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patientsJournal of Clinical Investigation, 2001
- 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Block Calcium-dependent Tyrosine Kinase Pyk2 Activation by Angiotensin II in Vascular Endothelial CellsJournal of Biological Chemistry, 2001
- Factor VIIa and Thrombin Induce the Expression of Cyr61 and Connective Tissue Growth Factor, Extracellular Matrix Signaling Proteins That Could Act as Possible Downstream Mediators in Factor VIIa·Tissue Factor-induced Signal TransductionJournal of Biological Chemistry, 2000
- Des-Arg10-kallidin Engagement of the B1 Receptor Stimulates Type I Collagen Synthesis via Stabilization of Connective Tissue Growth Factor mRNAJournal of Biological Chemistry, 2000
- Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cellsBasic Research in Cardiology, 1999
- Increased Expression of Connective Tissue Growth Factor in the Infarct Zone of Experimentally Induced Myocardial Infarction in RatsJournal of Molecular and Cellular Cardiology, 1998